For tumor radiotherapy, the in vivo detection of early cellular responses is important for predicting therapeutic efficacy. 
Introduction
Radiotherapy involves the use of high-energy X-rays or charged particles to treat malignancies with the intention of destroying or inactivating cancer cells while preserving normal tissue integrity (1) (2) (3) (4) . Many types of biomarkers are used to detect cell viability and responses after radiotherapy in vitro. Although cell apoptosis is an important marker, apoptosis after radiation is observed only in limited cell types, such as hematopoietic and germ cells. In addition, radiation exposure immediately induces a significant G 2 cellcycle arrest in many types of tumor cells (5) , as well as prolonged G 1 cell-cycle arrest in normal fibroblast and ependymal cells (6, 7) . The appearance ratio of the cell-cycle arrest linearly correlates with the radiation dose and cell viability in both normal and tumor cells (8) . In addition, radiation-induced cell-cycle arrest can be linked to irreversible growth arrest, such as senescence-like growth arrest (SLGA), which is associated with the expression of senescence-associated b-galactosidase (SA-b-gal; ref. 9 ). Thus, cell-cycle arrest and alteration can be an early biomarker for evaluating therapeutic efficiency immediately after radiotherapy.
The divalent manganese ion (Mn 2þ ) has long been known as a positive intracellular MRI contrast agent because of its ability to alter the longitudinal relaxation of water protons. Manganese-enhanced MRI (MEMRI) provides a unique opportunity to study neuronal activation and architecture (10) (11) (12) . The underlying principle of MEMRI lies in the fact that Mn 2þ behaves in a manner similar to the calcium ion (Ca 2þ ) in many biologic systems (13) . Extracellular Mn 2þ can enter cells through N-methyl-D-aspartate (NMDA) receptors for glutamate (14) and/or voltage-gated calcium channels (15) . Previous studies have found that MEMRI is useful for the in vivo visualization of tumors such as those arising from head and neck region (16, 17) . There are several reports, discussing the factors associated with Mn enhancement and tumor uptake. The tumor cell uptake of Mn 2þ is linked to the proliferation rate in vitro of human tumor cells (18) . In addition, Mn 2þ is considered to be a cell viability indicator in myocardial infarction (19, 20) . Therefore, it is possible that radiation-induced cell-cycle alteration and the associated suppression of cell proliferation can be detected from the alterations in MEMRI signal enhancement.
The goal of this study was to test the hypothesis that MEMRI can be used to detect radiation-induced alterations as an earlyphase tumor response after radiotherapy. In this study, we evaluated Mn 2þ uptake in a colon cancer cell line and a subcutaneous grafted mouse model by in vitro/in vivo MEMRI after X-ray exposure (20 Gy).
Materials and Methods

Colon cancer cells and in vitro irradiation experiment
The murine colon cancer cell line (colon-26) was maintained in Dulbecco's Modified Eagle Medium (DMEM; Sigma-Aldrich Japan) supplemented with 10% fetal calf serum (Nichirei) and 1% penicillin-streptomycin (Invitrogen Japan K.K.). Cells were cultured under high humidity with 5% CO 2 at 37 C. After incubation for 4 days, the colon-26 cells underwent a single exposure to X-rays at a dose of 20 Gy. The X-ray exposure conditions were: peak voltage of 200 kV, current of 20 mA, filter consisting of 0.5 mm Cu þ 0.5 mm Al, a distance between the focus and objective of 550 mm and a dose rate of 1.2 to 1.3 Gy/min. The radiation dose and colon-26 cell type were selected as a "less apoptotic model" based on the evidence described in a previous report (21) .
In vitro Mn 2þ uptake study by MRI We prepared 6 colon-26 cell pellets (control group, 3; radiation exposure group, 3) for MRI experiments at 24 hours after irradiation. The in vitro MRI acquisitions were carried out using a 7-T, 40 cm bore MRI magnet (Kobelco and Jastec) interfaced with a Bruker console (BioSpec, Bruker Biospin). A birdcage coil (38 mm inner diameter, transmission and reception; Rapid Biomedical) was used for the measurement of tumor cell samples. The samples were maintained at approximately 23 C. Manganese chloride (MnCl 2 ; MnCl 2 -4H 2 O, Sigma-Aldrich Japan) was dissolved in the DMEM at a concentration of 0.1 mmol/L. The cells were incubated in the medium, either with or without MnCl 2 , for 30 minutes at 37 C under 5% CO 2 . After incubation, the medium was carefully removed by washing twice with PBS. The cells were harvested and dissociated with trypsin, transferred to PCR tubes, and cell pellets were collected by centrifugation. For the T 1 -weighted image (T 1 WI), a 2-dimensional (2D), single-slice image was obtained using a conventional spin echo (SE) 
Flow cytometry for cell viability and cell-cycle assays
Cell apoptosis and cycle alterations were measured using Guava Viacount and Guava Cell Cycle Reagents (Guava Technologies Inc.), followed by analysis of the cells using a Guava PCA machine (Guava Technologies Inc.). Cells were placed in 4 plates and adhered overnight for 24 hours after radiation exposure. Cells were stained with Guava Viacount and Cell Cycle Reagents according to the manufacturer's instructions.
In vivo animal model and radiation exposure
The Animal Welfare Committee of our Institution approved all studies. Male BALB/c nu/nu mice (n ¼ 17, 21.3 AE 1.4 g, 8 weeks old; Japan SLC) were rested for 1 week before the experiment. The animals had free access to food and water and were kept under standard laboratory conditions in a specific pathogen-free environment, at 22 C to 23 C, with approximately 50% humidity, and a 12:12-hour light/dark cycle. Colon-26 cells (1 Â 10 7 ) were injected subcutaneously into both legs of the male BALB/c nu/nu mice. Seven days after the injection, the tumor-bearing mice were subjected to MRI and histologic experiments. All mice underwent a single X-ray exposure of the left leg (the right legs were covered by a 1 cm thick lead layer) at a dose of 20 Gy on day 7 after inoculation of colon-26 cells. The X-ray exposure conditions were as follows: peak voltage of 200 kV, current of 20 mA, filter consisting of 0.5 mm Cu þ 0.5 mm Al, a distance between the focus and objective of 550 mm, and a dose rate of 1.2 to 1.3 Gy/min. The male BALB/c nu/nu mice were divided into 2 groups (for MRI study, n ¼ 10; for tumor growth study, n ¼ 7). Following the radiation exposure, all mice, both control and radiation exposed, were maintained under 12:12 hour light/dark cycles until the MRI and tumor growth experiment.
In vivo MRI study
The mice were anesthetized with 2.0% isoflurane and placed in the prone position; the anesthesia was maintained at this level for MRI scanning. During the experiment, a warm flow of air over the animal maintained the body temperature at 37.0 C. The respiratory rate was maintained and monitored throughout the experiment using a rodent ventilator (MRI-1, CWE, Inc.). Before the T 1 WI acquisitions, scout images were acquired, and quantitative T 2 mapping was carried out to localize the tumor. T 2 mapping was done for the assessment of necrosis in the tumors using a multi-slice, multi-echo SE sequence (TR ¼ 3,000 ms, slice thickness ¼ 1 mm, FOV ¼ 40.0 Â 40.0 mm, matrix ¼ 256 Â 256, slice orientation ¼ transaxial, number of repetitions ¼ 1), with echo times ranging from 10 to 140 ms in steps of 10 milliseconds. The total acquisition time was 10 minutes and 20 seconds.
T 1 WI acquisition and quantitative T 1 mapping were carried out in the following order: preadministration (control), gadolinium (Gd)-enhanced, and Mn-enhanced experiments. First, one set of T 1 WIs and a T 1 map were acquired as baseline data before the administration of Gd. Second, the T 1 WI and T 1 map acquisition set was repeated 4 times every 16 minutes after the administration of gadopentetate dimeglumine (Gd-DTPA). Gd-DTPA (150 mmol/kg; Bayer Japan) was diluted to a concentration of 50 mmol/L with saline and injected intravenously to evaluate tumor vasculature. A waiting time of 90 minutes was included after the first and second steps to avoid potential Gd retention in tumors. Before the administration of MnCl 2 , we confirmed that the Gd-DTPA-related signal had returned to the baseline level. Third, T 1 WI and T 1 map acquisition sets were repeated 4 times every 16 minutes after starting the Mn infusion. Before the administration, 100 mmol/L MnCl 2 (MnCl 2 -4H 2 O, Sigma-Aldrich Japan) was dissolved in distilled water and diluted to 50 mmol/L with saline to match the osmotic pressure of blood. We slowly infused the 50 mmol/L, osmotic pressure-controlled MnCl 2 solution (380 mmol/kg) at a rate of 0.4 mL/h through the tail vein using a syringe pump (KDS-100, KD scientific, Inc.). In subcutaneous tumors, a 2D, single-slice T 1 , NA ¼ 1) and acquired over a period of 10 minutes and 40 seconds. For ROI studies, the first image set of 4 Gd-DTPA administration sets and third image set of 4 Mn administration sets were used. The ROIs of the subcutaneous tumor core and peripheral area were defined by the following methods. The outlines of the ROIs (ROI out ) were manually delineated on the T 1 WI. Gd-enhanced areas over the threshold level (þ2 SDs of the mean signal intensity of the ROI out in the control image) were then defined as the peripheral areas using first image set after Gd-DTPA injection. The peripheral areas were excluded from the ROI out . The areas that excluded the peripheral areas from the ROI out were defined as the tumor core areas.
Histology
All tumors were studied histologically to clarify the source of the T 1 change. Mice were euthanized by pentobarbital (1.0 mL/animal; Dainippon-Sumitomo Pharmaceutical) overdose after the MRI scans and were prepared for histology by transcardiac perfusion with saline-containing heparin followed by 4% paraformaldehyde (Otsuka Pharmaceutical Co., Ltd.). Tissues were embedded in paraffin and transaxially sectioned into 4 mm thick sections, which were then placed on slides at the locations and orientations corresponding to the MRI slices. The slides were processed for cyclin D1 (Nichirei Biosciences Inc.), Ki-67 (Dako Japan Inc.), and activated caspase-3 (Cell Signaling Technology Japan) staining. After visualization with diaminobenzidine (DAB; DAKO Japan Inc.), tissue sections were briefly counterstained with hematoxylin. Three types of staining were conducted for each tumor. Cyclin D1 (for the detection of cell-cycle alterations) and Ki-67 (for the assessment of tumor proliferation) were identified as follows; (i) the brightness and contrast were automatically optimized using Photoshop (Ver. 8.0.1, Adobe, Inc.); (ii) the brown-stained positive cells were enhanced and converted to a black and white binary map using the "Make binary" plug-in of ImageJ (Ver.1.40g, NIH); (iii) the total area of the black regions of the binary map was measured using the "ROI" and "Measure" plug-ins of ImageJ; (iv) the ratio of the positive cell area to the total area was calculated. To identify cells that underwent apoptosis as a result of radiation exposure, the number of positive cells per square millimeter of tumor was calculated in the activated caspase-3-stained slices.
Tumor growth study
In
, where a and b are the largest and smallest perpendicular tumor diameters, respectively. Subsequent measurements were normalized to the pretreatment tumor volume.
Statistical analysis
The data are presented as the mean AE SD. All statistical analyses were conducted using Prism 5 (Version 5.0, GraphPad Software, Inc.). Longitudinal relaxation rates (R 1 ¼ 1/T 1 ) before and after MnCl 2 administration in the control and radiationexposed tumors were calculated. We compared control and radiation-exposed groups using the unpaired t test and considered values of P < 0.05 to be significant for the in vitro Mnuptake study, tumor size analysis, in vivo T 2 quantitative MRI data analysis, and histologic experiments. A one-way ANOVA with Tukey post hoc test was applied to compare R 1 values between tumors.
Results
In vitro imaging of tumor cells using MEMRI Figure 1A shows T 1 -weighted MR images of the pellets of colon-26 cells, either exposed or not exposed to radiation, after incubation in a standard medium with or without 0.1 mmol/L MnCl 2 supplementation. Irradiated colon-26 cells showed less signal enhancement compared with control colon-26 cells after MnCl 2 administration at 24 hours after X-ray irradiation (Fig. 1A) . The 
Tumor growth
The tumor size ratio with respect to the pretreatment size is shown in Fig. 3 for both groups. There was no significant difference between the tumor sizes of 2 groups 1 day after radiation exposure, although the volume of the irradiated tumor was significantly smaller than that of the control groups on the third and seventh days (P < 0.001).
In vivo tumor imaging using MEMRI
We used Gd-DTPA to evaluate tumor vasculature condition and exclude the area where Gd-DTPA was highly accumulated because of disruption of the intratumor microvasculature. The core areas of control and radiation-exposed tumors were homogeneously and almost equally enhanced by Gd-DTPA (Fig. 4A) . After disappearance of the Gd-enhancement (typically within 60 minutes), we obtained MEMRI with systemic MnCl 2 administration. In contrast to Gd-enhanced MRI, the control tumors were preferentially enhanced by MnCl 2 in the Figure 3 . Tumor volume measurements. Tumor growth was significantly retarded in the radiation-exposed group after 3 and 7 days ( ÃÃÃ , P < 0.001). There was no significant difference between the tumor sizes of 2 groups 1 day after treatment. The core areas of control and radiation-exposed tumors were homogeneously and almost equally enhanced by Gd-DTPA (A, middle). In MEMRI, the control tumor was preferentially enhanced in comparison with the radiation-exposed tumor following MnCl 2 administration (A, bottom). The signal intensity is indicated by the color bar (arbitrary unit). B, the R 1 values in the peripheral area and the core of the tumors. There are no differences in the peripheral area R 1 values between the 2 tumor types. The R 1 values in the core areas of the control tumors were significantly higher at 30 minutes after Mn 2þ administration than that in the radiation-exposed tumors ( ÃÃÃ , P < 0.001). C, the T 2 -map of the X-ray-treated and control tumors. There are no differences between both tumor T 2 values.
T 1 WI in comparison with the radiation-exposed tumors (Fig.  4A) . Figure 4B shows the R 1 values in the peripheral and core areas of the tumors. There were no differences in the tumor R 1 values in the peripheral areas between the 2 tumor types ( Fig.  4B ; peripheral: control, 0.61 AE 0.01 s À1 and radiation-exposed, 0.60 AE 0.01 s À1 ). However, the R 1 values in the core areas of the control tumor were significantly higher at 30 minutes following Mn 2þ administration in comparison with those of the radiation-exposed tumors ( Fig. 4B ; core, P < 0.001; control, 1.10 AE 0.02 s À1 and radiation-exposed, 0.97 AE 0.02 s À1 ). T 2 maps of the radiation-exposed and control tumors were calculated (control, 52.3 AE 1.5 ms; radiation-exposed, 52.1 AE 1.2 ms). There were no differences between the T 2 values of the tumors (Fig. 4C ). Figure 5A -I shows the results of the immunohistochemical staining for the evaluation of cellular alterations in the tumor core 24 hours after radiation exposure. The immunohistologic stainings for cyclin D1 and Ki-67 indicated that both cell cycle and proliferation in the radiation-exposed tumor core were significantly changed ( Fig. 5C ; cyclin D1, P < 0.01: control, 14.9 AE 2.0% and radiation-exposed, 11.0 AE 2.4%, P < 0.01; and Fig. 5F ; Ki-67: control, 8.6 AE 1.6% and radiation-exposed, 5.9 AE 0.6%, P < 0.001). On the other hand, the number of apoptotic cells per section was not significantly different between the radiation-exposed and control tumors (Fig. 5I , control: 2.0 AE 0.7 and radiation exposed: 2.2 AE 0.8).
Immunohistochemical staining of tumors
Discussion
Relationship between radiation-induced cell-cycle alteration and Mn 2þ uptake Ca 2þ is required to maintain normal structure and function in all living cells (22) and participates in a variety of physiologic and biologic events such as proliferation and apoptosis (23) . In vitro calcium imaging is a common technique frequently carried out in studies that are designed to show the Ca 2þ status of a tissue or a medium. In particular, the dynamics of intracellular Ca 2þ can only be analyzed by optical methods using calcium-sensitive dyes for the detection of Ca 2þ -bound fluorescence in vitro (24) . Recently, in vivo MEMRI has provided a unique opportunity to study neuronal activation and architecture due to the ability of Mn 2þ as a calcium surrogate (10) (11) (12) . Mn 2þ can enter cells via the same transport systems as those used by Ca 2þ and can bind to a number of intracellular structures with high-affinity Ca 2þ -and Mg 2þ -binding sites on proteins and nucleic acids (25) . Mn 2þ as a positive contrast agent in T 1 W MRI has long been used in many biologic applications for brain mapping (26), brain disease (12) (27) , neuronal tract tracing (28) , and cardiac functional studies (29) . Although several factors influencing Mn 2þ uptake in cells have been reported such as voltage-gated Ca 2þ -channel activities (30) (31) (32) (33) , NMDA (14) and calcium-sensing receptor (34) expression, astroglia (27) and microglia (35) activity/cellularity, activities of enzymes (e.g., manganese superoxide dismutase; refs. 36, 37) and metal transporters, the mechanisms involved in Mn 2þ uptake in tumor cells are not well known. Some previous studies have shown that MEMRI can enhance some types of tumors in vivo, such as salivary gland and eye (choroidal) tumors (16, 17) . In particular, Braun and colleagues showed that the uptake of Mn 2þ by tumors depends on the cellproliferation rate (18) . Thus, we conducted a MnCl 2 loading study to investigate whether Mn 2þ is accumulated in tumor cells that have undergone G 2 -M cell-cycle arrest due to radiation exposure. Mn 2þ accumulation was decreased in radiation-exposed tumor cells both in vitro and in vivo (Fig. 1B and Fig. 4A ) with cell-cycle alteration as early as 24 hours after irradiation, when insignificant increase in apoptotic cells was observed ( Fig. 2D and Fig. 5C ). These results suggest that the cell-cycle alteration of tumor cells is an important determinant of the uptake of Mn2þ in MEMRI, and that the apoptosis of tumor cells is not a predominant factor in the decrease of Mn2þ uptake for our the 20-Gy radiation condition. At most, less than 10% increment in the number of apoptotic cells may induce a small signal reduction.
Intracellular free Ca 2þ has been proposed to play a role in the regulation of the cell cycle (38) and in the progression into mitosis from the G 2 arrest point (39) . In the late G 2 phase, cells with activated cdc2 kinase can enter into mitosis (40) . However, radiation exposure induces a significant G 2 cell-cycle arrest (5, 41) and decreased functioning of cdc2 kinase (41) . The local transient increase in free Ca 2þ influences the rate of cdc2 kinase activation, and it is necessary to initiate pathways leading to cdc2 kinase inactivation in the mitotic cell cycle (42) . Therefore, we suggest that the decrease in Ca 2þ uptake due to inactivated cdc2 kinase contributes to MEMRI signal reduction in the radiation-exposed model.
Factors involved in Mn
2þ uptake in radiation-exposed tumor cells
Other factors can alter the uptake of the Mn 2þ contrast agent in tumor cells. For example, cell viability (apoptotic or necrotic change) and density affect Mn 2þ uptake in MEMRI. Hu and colleagues showed that Mn 2þ acts as a viability marker depending on Ca 2þ -channel activity in myocardial ischemia (29) . This result suggests that living cells can accumulate higher amount of Mn 2þ than infracted cells. In our study, neither apoptosis nor necrosis was detected in the in vivo radiation-exposed or control tumors (Figs. 4C and 5I ). In addition, exclusion of apoptotic cells from radiationexposed tumor cells using a cell sorter did not strongly affect the MRI signal in comparison with that from nonsorted irradiated cells in vitro (Supplementary Fig. S1 ). In contrast, cell-cycle alterations were clearly detected in both in vitro and in vivo irradiated tumor cells using flow cytometry (Fig. 2) and cyclin D1 staining (Figs. 2 and 5C ). Although apoptosis and apoptotic stimuli are linked to cell-cycle regulators (43) , under the condition of our radiation dose and tumor model, apoptosis-altered cells did not significantly affect the MRI signal because the number of apoptotic cells was comparatively small.
In previous work, it was reported that Mn 2þ uptake in the tumor is linked to the proliferation rate of tumor cells (18) . In our study, the number of Ki-67-positive cells (potential marker of tumor growth activity; refs. 44, 45) and the MEMRI signal were decreased at 24 hours after irradiation (Fig. 5F ). The Ki-67 (Fig. 5) and MEMRI observations agreed well with a previous report (18) and suggested that the Mn 2þ accumulation in tumors, when evaluated during the early phase (24 hours) after irradiation, reflects cell-cycle alteration and a subsequent decrease in cell proliferation rather than apoptotic alterations.
Tumor vascularization is an important factor that affects the uptake of contrast agents in tumor-bearing animals. We evaluated vasculature conditions inside the tumor using an extracellular Gd-DTPA contrast agent before all MEMRI experiments (Gd-DTPA does not affect the MEMRI signal because the extracellular agent is not accumulated in the tumor and is rapidly excreted within approximately 1 hour after administration). In most cases, there was no regional enhancement inside tumors, either with or without radiation exposure, after Gd-DTPA administration (Fig. 4A ). In addition, dynamic contrast-enhanced MRI (Supplementary Fig. S2 ; tumor microcirculation) and CD-31 immunohistologic staining (Supplementary Fig. S4 ; structure of vascular endothelial cells) showed that there was no significant difference in the vessel structure between the control and radiation-exposed tumors. Therefore, the 20-Gy radiation exposure for the colon-26 tumor cells did not damage the microvessel structure at 1 day in vivo. Consequently, it is thought that vasculature disruption in the tumor did not affect the MEMRI signal at 1 day in our model. In addition, necrotic or inflammatory alterations and bleeding in the tumors were not observed based on the T 2 values (Fig.  4C ) and hematoxylin and eosin (H&E) staining (Supplementary Fig. S3 ).
In conclusion, we used MEMRI to observe the Mn 2þ uptake in X-ray-exposed models of in vitro tumor cells and an in vivo tumor-bearing animal model. The irradiated colon-26 tumor cells underwent cell-cycle alterations (leading to decreased proliferation) but did not exhibit serious apoptotic/necrotic/ inflammatory alterations or vascular damage early after irradiation. MEMRI and quantitative maps of the relaxation rate (R 1 ) map showed a significant signal reduction both in vitro and in vivo. Our data provides evidence that MEMRI will be a useful tool for the early evaluation and optimization of radiotherapy in the near future, enabling the imaging of cell-cycle arrest and the associated suppression of cell proliferation in vivo. 
